Multimodal Laser Treatment of Photodamaged Skin
Sponsor: Merete Haedersdal • ClinicalTrials.gov ID: NCT07789002
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
The Multimodal Laser Project is a prospective, randomized, split-face clinical study investigating a novel combination of laser and light-based treatments for facial photodamage with the long-term perspective of improving skin cancer prevention. The study includes 35 patients with facial photodamage and AKs. One side of the face receives a multimodal treatment combining three complementary technologies: 1927-nm thulium laser, 1550-nm non-ablative fractional laser, and intense pulsed light (IPL), while the contralateral side serves as an untreated control. Participants are followed for 14 months to assess both clinical efficacy and longer-term preventive effects. The overall aim is not only to determine whether multimodal laser treatment improves photodamaged skin, but also to gain a deeper understanding of how the treatment affects the underlying biology of chronically sun-damaged skin and its potential role in skin cancer prevention.
Interventions
-
1927-nm thulium laser
(Device)
Fractional non-ablative 1927-nm thulium laser treatment applied to the randomized intervention side of the face
-
1550-nm Er:Glass laser
(Device)
Fractional non-ablative 1550-nm Er:Glass laser treatment applied to the randomized intervention side of the face
-
Intense Pulsed Light
(Device)
Intense pulsed light treatment applied to the randomized intervention side of the face
Eligibility criteria
Conditions
Locations
- Department of Dermatology, Bispebjerg Hospital — Copenhagen NV, Denmark
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record